Closed-end funds that invest in healthcare companies
7 of the 361 U.S. closed-end funds we cover invest in healthcare companies.
They are run by 3 firms; the largest are abrdn (4), BlackRock (2) and Gabelli (1).
At 2 of them a large investor is pushing for changes.
Yearly costs run from 1.1% to 3.2%.
7 funds
Sort by: name · yearly cost · borrowing · size
- HQH - abrdn Healthcare Investors
Run by abrdn. Invests in healthcare companies. Costs 1.1% a year. Does not borrow. - THQ - abrdn Healthcare Opportunities Fund
Run by abrdn. Invests in healthcare companies. Costs 3% a year. Borrows 22%. - HQL - abrdn Life Sciences Investors
Run by abrdn. Invests in healthcare companies. Costs 1.2% a year. Does not borrow. - THW - abrdn World Healthcare Fund
Run by abrdn. Invests in healthcare companies. Costs 3% a year. Borrows 18%. - BMEZ - BlackRock Health Sciences Term Trust
Run by BlackRock. Invests in healthcare companies. Costs 1.4% a year. Does not borrow. - BME - BlackRock Health Sciences Trust
Run by BlackRock. Invests in healthcare companies. Costs 1.1% a year. Does not borrow. - GRX - Gabelli Healthcare & WellnessRx Trust
Run by Gabelli. Invests in healthcare companies. Costs 3.2% a year. Borrows 33%.
Details: the same funds as a table
| Fund | Yearly cost | Borrowing | Size |
|---|---|---|---|
| HQH - abrdn Healthcare Investors | 1.1% | none | $1.36 billion |
| THQ - abrdn Healthcare Opportunities Fund | 3% | 22% | $826 million |
| HQL - abrdn Life Sciences Investors | 1.2% | none | $689 million |
| THW - abrdn World Healthcare Fund | 3% | 18% | $566 million |
| BMEZ - BlackRock Health Sciences Term Trust | 1.4% | none | $1.08 billion |
| BME - BlackRock Health Sciences Trust | 1.1% | none | $571 million |
| GRX - Gabelli Healthcare & WellnessRx Trust | 3.2% | 33% | $153 million |